Charlotte Foote joining our team as a Junior Scientist Charlotte recently graduated from the University of Exeter with a degree in Neuroscience where she completed her dissertation analysing hippocampal network activity in a transchromosomic mouse model of Down syndrome. She investigated whether signatures of electrical neuronal network activity in the dentate gyrus, which is vulnerable to malfunction caused by trisomy 21, are disrupted in different behavioural states. Alongside her degree, she independently completed courses in Machine Learning and Computational Neuroscience which developed her knowledge of the processing required in neural networks. Charlotte is pleased to be joining Neuro-Bio for a 10-week internship to contribute to the development of a therapeutic for Alzheimer’s Disease.
Neuro-Bio Ltd
Biotechnology Research
Oxford, Oxfordshire 1,651 followers
Neuro-Bio is a privately-owned biotech out of Oxford University with a therapeutic focus on neurodegenerative disease.
About us
‘Neuro-Bio has discovered a novel 14 amino acid bioactive peptide (T14) derived from the C terminus of AChE. T14 is neurotoxic in the adult brain and published data shows it to be a potential key driver of neurodegeneration. This new distinct mechanism is being exploited by Neuro-Bio to discover first-in-class drugs to treat Alzheimer's disease and to develop a biomarker as a companion diagnostic’.
- Website
-
http://www.neuro-bio.com
External link for Neuro-Bio Ltd
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Oxford, Oxfordshire
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Neurobiology, Neurodegeneration, Drug discovery, Biomarker development, Biotechnology, and CNS Disorders
Locations
-
Primary
Culham Campus
Abingdon
Oxford, Oxfordshire OX14 3DB, GB
Employees at Neuro-Bio Ltd
Updates
-
Marta Perez Gonzalez joining our team at NeuroBio as a Senior Scientist Marta received a BSc in Biotechnology from the University of Oviedo in 2014. After that, she got a MSc in Biomedical Research and a PhD in Neuroscience and Cognition at the University of Navarra. During her time in Navarra, Marta identified and validated a novel therapeutic strategy for Alzheimer’s disease (AD) and tested the efficacy of different small molecules for AD treatment. She then moved to University College London to work as postdoctoral research fellow, first in the department of Clinical and Experimental Epilepsy and lately in the department of Neuromuscular Disorders where she worked on Down syndrome. Marta’s expertise includes cellular, molecular and behavioural biology. She joined Neuro-Bio as Senior Scientist.
-
Neuro-Bio featured in the UK Ageing Network (UKAN) Newsletter – July 2024 The UK Ageing Network (UKAN) is made up of 11 interdisciplinary ageing research networks, bringing together researchers and stakeholders from different disciplines to better understand the biological mechanisms of ageing and their impact on human health. https://lnkd.in/db_XEJX
-
Neuro-Bio welcomes students from City of Oxford College Neuro-Bio welcomed a group of 10 students from the City of Oxford College on Wednesday 26th June, who are studying the programmes of Forensic Science and the Applied Science. The students were introduced to Neuro-Bio’ science by Professor Susan Greenfield and visited the labs where they had the opportunity to meet the scientific team and to understand how a biotech company works. Their Group Director of Academic Studies, Hannah O’Neill, shared the following feedback: “Students found the research exciting and enjoyed hearing about different techniques and industrial applications of their studies in college. All the students were very grateful for the opportunity. Many students were motivated to pursue internship to gain work experience following the visit too, which is exactly what we hoped to achieve.” We will be welcoming more students from City of Oxford College in the new academic year.
Neuro-Bio welcomes students from City of Oxford College - NeuroBio
https://neuro-bio.com
-
On the 19th of June Baroness Greenfield gave an inspirational talk at the Early Career Researcher Retreat on the progress being made at Neuro-Bio on how to combat and diagnose this more and more common disease. Research is what is needed to understand how, when and where our brains succumb to this so far unchallenged disease.
I was truly delighted to attend the Early Career Researcher Retreat on behalf of Alzheimer's Society last week in Solihull. As we all know, research brings hope to us all in whatever illness you/we are going through, and I was honoured to share Neuro-Bio Ltd research on the devastating Alzheimer's Disease. Let's continue to raise awareness, and hopefully find a cure for this cruel disease.
-
Neuro-Bio is a finalist at the Thames Valley Tech & Innovation Awards 2024! We are extremely excited and proud to be a finalist at the Thames Valley Tech & Innovation Awards this year. The category we are up for is: “Life Sciences & Health Tech Company of the Year” This shows how much hard work and effort the whole team has put in to researching how to combat this dreadful disease. To find out more about Neuro-Bio Ltd and what we have been up to, please have a look at our website and news section below: https://lnkd.in/db_XEJX
Neuro-Bio Has A Theraputic Focus On Neurodegenerative Disease Drugs
https://neuro-bio.com
-
Neuro-Bio Ltd reposted this
It's Alzheimer’s and Brain Awareness Month. Let's continue to raise awareness and support those who are affected by Alzheimer's Disease and other devastating brain disorders. There are over 55 million people worldwide living with this cruel disease, and this is expected to increase! We need to continue to educate ourselves and our communities about the signs, symptoms, and impact of these diseases to promote early detection and intervention. Here are just some of the things to look out for: - Memory loss that disrupts daily life: forgetting events, repeating yourself or relying on more aids to help you remember (like sticky notes or reminders). - Challenges in planning or solving problems: having trouble paying bills or cooking recipes you have used for years. - Difficulty completing familiar tasks at home, at work, or at leisure: having problems with cooking, driving places, using a cell phone or shopping. - Confusion with time or place: having trouble understanding an event that is happening later or losing track of dates. - Trouble understanding visual images and spatial relations: having more difficulty with balance or judging distance, tripping over things at home, or spilling or dropping things more often.
-
Baroness Susan Greenfield attends NeuRA, Australia May 2024! To read more, please visit our news section below: https://lnkd.in/dkYrNqmr
Latest News From Neuro-Bio, A Neurodegenerative Biotech Company
https://neuro-bio.com
-
Neuro-Bio Ltd reposted this
I'm excited to share my 2 episodes which were kindly captured by NeuRA (Neuroscience Research Australia) during my stay in Sydney. I presented a talk to a live audience "Can Science be Creative?" as well as a more personal discussion with Carole Renouf (Executive Director) on my journey to Neuroscience. To view both of my talks click on the link below in NeuRA (Neuroscience Research Australia) post.
We are thrilled to announce the release of two special episodes of #NeuRATalks featuring the world-renowned neuroscientist, author, CEO, and our inaugural 'Rockstar' neuroscientist in residence, Baroness Susan Greenfield CBE. These episodes capture two of Baroness Greenfield's inspiring talks presented to a live audience at NeuRA last week: Can science be creative? and an exclusive fireside chat, 'Up close and personal with Baroness Greenfield.' NeuRA Talks is a free and insightful online video series produced here at NeuRA, showcasing the bright minds behind our research and impact. 📺 Tune in here: https://lnkd.in/g8dpiFAT #NeuroStarAtNeuRA
-
Neuro-Bio Ltd, in collaboration with an international team of clinicians and neuroscientists, have published an insightful perspective which offers an alternative to the amyloid hypothesis in the etiology of Alzheimer's disease. Their review, published in Alzheimer's & Dementia, presents evidence of a pivotal molecule, T14, which could serve as a pre-symptomatic biomarker for neurodegeneration and inspire new therapeutic strategies for Alzheimer's disease. #AlzheimersResearch #Neurodegeneration #NeuroBioLtd
Researchers examine evidence for a novel neuronal mechanism driving Alzheimer's disease
medicalxpress.com